Increase in Private Testosterone Prescribing May Lead to Overtreatment and NHS Strain

Experts warn that the rapid growth of private testosterone prescriptions could result in overtreatment, extending therapy to men with non-specific symptoms and borderline test results. This trend raises concerns about uncertain long-term benefits and risks, potentially placing additional strain on the NHS. The caution comes amid growing use of testosterone treatments beyond clearly defined medical needs.

Originally published by gnews